tiprankstipranks
Advertisement
Advertisement

HK:3692 Stock Latest News

Hansoh Pharmaceutical Shareholders Approve All Resolutions at 2026 AGM
Company AnnouncementsHansoh Pharmaceutical Shareholders Approve All Resolutions at 2026 AGM
6d ago
3692
Hansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication
22d ago
3692
Hansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary
PremiumCompany Announcements
Hansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary
22d ago
3692
Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates
PremiumCompany Announcements
Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates
28d ago
3692
Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China
PremiumCompany Announcements
Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China
28d ago
3692
Hansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug
PremiumCompany AnnouncementsHansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug
1M ago
3692
Hansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles
Premium
Company Announcements
Hansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles
2M ago
3692
Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug
Premium
Company Announcements
Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug
2M ago
3692
Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC
PremiumCompany Announcements
Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC
2M ago
3692
Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases
PremiumCompany Announcements
Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases
2M ago
3692
Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
PremiumCompany Announcements
Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
2M ago
3692
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
PremiumCompany Announcements
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
2M ago
3692
Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
PremiumCompany AnnouncementsHansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
2M ago
3692
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
Premium
Company Announcements
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
2M ago
3692
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
Premium
Company Announcements
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
2M ago
3692
Hansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme
PremiumCompany Announcements
Hansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme
2M ago
3692
Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo
PremiumCompany Announcements
Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo
3M ago
3692
Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
PremiumCompany Announcements
Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
3M ago
3692
Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025
PremiumCompany Announcements
Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025
3M ago
3692
Hansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio
PremiumCompany AnnouncementsHansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio
3M ago
3692
Hansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587
Premium
Company Announcements
Hansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587
3M ago
3692
Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug
Premium
Company Announcements
Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug
3M ago
3692

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >